Perlberg; Anett

Patent Applications and Registrations

Patent applications and USPTO patent grants for Perlberg; Anett.The latest application filed is for "crystalline form of pemirolast".

Company Profile

0.11.12

Perlberg; Anett - Gunzgen CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystalline Form of Pemirolast App 20170202839 - Perlberg; Anett ; et al.	2017-07-20
Crystalline Form Of Pemirolast App 20160250217 - Perlberg; Anett ; et al.	2016-09-01
Salts of 7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptan- oic acid as IP receptor agonists Grant 9,174,985 - Leblanc , et al. November 3, 2	2015-11-03
Methods of treating diabetes Grant 9,067,962 - De Paul , et al. June 30, 2	2015-06-30
Crystalline form of pemirolast Grant 9,006,431 - Perlberg , et al. April 14, 2	2015-04-14
Salts of an IP Receptor Agonist App 20150011555 - Leblanc; Catherine ; et al.	2015-01-08
New Crystalline Form of Pemirolast App 20140329839 - Perlberg; Anett ; et al.	2014-11-06
Crystalline form Grant 8,809,340 - Howsham , et al. August 19, 2	2014-08-19
Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phen- yl)-2,2,2-trifluoroethoxy)-pyrimidin-4-yl)phenyl)propanoate and methods of their use Grant 8,653,094 - Bednarz , et al. February 18, 2	2014-02-18
Novel Crystalline Form App 20130345239 - Howsham; Catherine ; et al.	2013-12-26
Methods Of Treating Diabetes App 20130165395 - De PAUL; Susan Margaret ; et al.	2013-06-27
Solid Forms Of (s)-ethyl 2-amino-3-(4-(2-amino-6-((r)-1-(4-chloro-2-(3-methyl-1h-pyrazol-1-yl)phen- Yl)-2,2,2-trifluoroethoxy)-pyrimidin-4-yl)phenyl)propanoate And Methods Of Their Use App 20130005754 - BEDNARZ; Mark S. ; et al.	2013-01-03
Solid forms of (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetr- ahydro-2H-pyran-3,4,5-triol and methods of their use Grant 8,217,156 - De Paul , et al. July 10, 2	2012-07-10
New Crystalline Form of Pemirolast App 20120157415 - Perlberg; Anett ; et al.	2012-06-21
Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1- (4-chloro-2-(3-methyl-1H-pyrazol-1-YL)phenyl)2,2,2-trifluoroethoxy)-pyrim- idin-4-YL)phenyl)propanoate and methods of their use Grant 8,193,204 - Bednarz , et al. June 5, 2	2012-06-05
Solid Forms Of (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetr- Ahydro-2h-pyran-3,4,5-triol And Methods Of Their Use App 20100016422 - De Paul; Susan Margaret ; et al.	2010-01-21
Solid Forms Of (s)-ethyl 2-amino-3-(4-(2-amino-6-((r)-1-(4-chloro-2-(3-methyl-1h-pyrazol-1-yl)phen- Yl)-2,2,2-trifluoroethoxy)-pyrimidin-4-yl)phenyl)propanoate And Methods Of Their Use App 20090088447 - Bednarz; Mark S. ; et al.	2009-04-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.